Share on Facebook
Share on Twitter
Share on LinkedIn
Share by Email
Print
Tussicaps 5mg/4mg Generic Name & Formulations
Legal Class
CII
General Description
Hydrocodone bitartrate 5mg, chlorpheniramine maleate 4mg; as polistirex; ext-rel caps; contains alcohol.
Pharmacological Class
Antitussive + antihistamine.
See Also
How Supplied
Caps—20, 100
Manufacturer
Tussicaps 5mg/4mg Indications
Indications
Cough and upper respiratory symptoms.
Tussicaps 5mg/4mg Dosage and Administration
Adult
1 cap (10mg/8mg) every 12hrs; max 2caps/24hrs.
Children
<6yrs: see Contraindications. 6–11yrs: 1 cap (5mg/4mg) every 12hrs; max 2caps/24hrs.
Tussicaps 5mg/4mg Contraindications
Contraindications
Children <6yrs of age (risk of fatal respiratory depression).
Tussicaps 5mg/4mg Boxed Warnings
Not Applicable
Tussicaps 5mg/4mg Warnings/Precautions
Warnings/Precautions
Respiratory depression. Post–op. Pulmonary disease. Head injury. Increased intracranial pressure. Glaucoma. Asthma. GI or GU obstruction. Acute abdomen. Severe hepatic or renal impairment. Hypothyroidism. Addison's disease. Elderly. Debilitated. Labor & delivery. Pregnancy (Cat.C). Nursing mothers: not recommended.
Tussicaps 5mg/4mg Pharmacokinetics
See Literature
Tussicaps 5mg/4mg Interactions
Interactions
Additive CNS depression with alcohol, other CNS depressants, tricyclic antidepressants, MAOIs. Paralytic ileus with concurrent anticholinergics.
Tussicaps 5mg/4mg Adverse Reactions
Adverse Reactions
Nausea, vomiting, CNS and respiratory depression, ureteral and vesical sphincter spasm, chest tightness, abuse potential, anticholinergic effects, rash, pruritis.
Tussicaps 5mg/4mg Clinical Trials
See Literature
Tussicaps 5mg/4mg Note
Not Applicable
Tussicaps 5mg/4mg Patient Counseling
See Literature
Images
